chr20-63693160-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PP3_ModeratePP5
The NM_001283009.2(RTEL1):c.2869C>T(p.Arg957Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000428 in 1,612,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R957P) has been classified as Uncertain significance.
Frequency
Consequence
NM_001283009.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001283009.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RTEL1 | NM_001283009.2 | MANE Select | c.2869C>T | p.Arg957Trp | missense | Exon 30 of 35 | NP_001269938.1 | ||
| RTEL1 | NM_032957.5 | c.2941C>T | p.Arg981Trp | missense | Exon 30 of 35 | NP_116575.3 | |||
| RTEL1 | NM_016434.4 | c.2869C>T | p.Arg957Trp | missense | Exon 30 of 35 | NP_057518.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RTEL1 | ENST00000360203.11 | TSL:5 MANE Select | c.2869C>T | p.Arg957Trp | missense | Exon 30 of 35 | ENSP00000353332.5 | ||
| RTEL1 | ENST00000508582.7 | TSL:2 | c.2941C>T | p.Arg981Trp | missense | Exon 30 of 35 | ENSP00000424307.2 | ||
| RTEL1 | ENST00000370018.7 | TSL:1 | c.2869C>T | p.Arg957Trp | missense | Exon 30 of 35 | ENSP00000359035.3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152082Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000401 AC: 10AN: 249160 AF XY: 0.0000517 show subpopulations
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1459956Hom.: 0 Cov.: 33 AF XY: 0.0000358 AC XY: 26AN XY: 726274 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152082Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74282 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Dyskeratosis congenita, autosomal recessive 5 Pathogenic:3
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Dyskeratosis congenita Pathogenic:2
Variant summary: RTEL1 c.2941C>T (p.Arg981Trp), also reported as p.R734W and p.R957W, results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 4e-05 in 249160 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in RTEL1 causing Dyskeratosis Congenita (Hoyeraal Hreidarsson Syndrome) (4e-05 vs 0.0011), allowing no conclusion about variant significance. c.2941C>T has been observed in the compound heterozygous and homozygous states in multiple individual(s) affected with clinical features and/or diagnosis of Dyskeratosis Congenita (Hoyeraal Hreidarsson Syndrome) (example, Walne_2013, Touzot_2016). It has also been observed in the heterozygous state in multiple individuals with and without family history of pulmonary fibrosis (example, Borie_2019, Fang_2020). These data indicate that the variant is likely to be associated with disease. Multiple reports provide experimental evidence that this variant is associated with reduced DNA replication fork function/partner protein interaction in vitro and decreased telomere length in vivo (example, Walne_2013, Takedachi_2020, Touzot_2016). The following publications have been ascertained in the context of this evaluation (PMID: 23829372, 23453664, 24582487, 30523160, 32583532, 39279213, 32398829, 29296694). ClinVar contains an entry for this variant (Variation ID: 42021). Based on the evidence outlined above, the variant was classified as likely pathogenic.
not provided Pathogenic:1Uncertain:1
Observed in the heterozygous state in unrelated patients with pulmonary fibrosis in published literature (PMID: 30523160, 32583532); Published functional studies demonstrate telomere shortening, increased T-circle formation, and replication fork stalling (PMID: 23453664, 29296694, 32398829); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as R957W and R734W; This variant is associated with the following publications: (PMID: 30523160, 34183866, 27415407, 28714244, 25940403, 23453664, 32583532, 29296694, 28099038, 24582487, 32398829)
Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Pathogenic:1Uncertain:1
Based on the classification scheme VCGS_Germline_v1.3.5, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with autosomal dominant dyskeratosis congenita 4 and autosomal recessive dyskeratosis congenita 5 (MIM#615190), and autosomal dominant pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 3 (MIM#616373). (I) 0108 - This gene is associated with both recessive and dominant disease. Currently, the genotype-phenotype relationship has not been established (OMIM). (I) 0112 - The condition associated with this gene has incomplete penetrance. Monoallelic pathogenic variants have been reported in asymptomatic family members (PMID: 23329068, 25848748, 35199181). (I) 0115 - Variants in this gene are known to have variable expressivity (OMIM). (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v4: 69 heterozygotes, 0 homozygotes). (SP) 0309 - Multiple alternative amino acid changes at the same position have been observed in gnomAD (v4) (highest allele count: 31 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0710 - Other missense variants comparable to the one identified in this case have inconclusive previous evidence for pathogenicity. Two alternative changes, p.(Arg947Gln) and p.(Arg957Pro), have been classified as VUS by clinical laboratories in ClinVar. p.(Arg957Gln) was also observed in a large chronic hypersensitivity pneumonitis cohort (PMID: 31268371). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as likely pathogenic by five clinical laboratories and as a VUS by two clinical laboratories in ClinVar. It has been reported in three compound heterozygous families and one homozygous individual with features consistent with autosomal recessive dyskeratosis congenita (PMIDs: 23453664, 29296694). This variant has also been identified in individuals with idiopathic pulmonary fibrosis and interstitial lung disease and has been classified as a VUS and pathogenic (personal communication, PMIDs: 30523160, 32583532). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign
The variant is observed at an allele frequency greater than expected for the associated disorder in the gnomAD v2.1.1 dataset and therefore considered benign. Predicted Consequence/Location: Missense variant Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000042021). This variant has been reported to be associated with both dykeratosis congenita (PMID: 29296694) and pulmonary fibrosis (PMID: 30523160). Therefore, this variant is classified as VUS according to the recommendation of ACMG/AMP guideline.
RTEL1-related disorder Pathogenic:1
The RTEL1 c.2941C>T variant is predicted to result in the amino acid substitution p.Arg981Trp. This variant has been reported in the compound heterozygous state with a second RTEL1 variant in three unrelated patients with autosomal recessive dyskeratosis congenita (DC) and segregated with DC in all the families (Walne et al 2013. PubMed ID: 23453664). Functional studies of patient cells showed significant defects in telomere maintenance (Walne et al 2013. PubMed ID: 23453664). This variant has also been reported in the heterozygous state in three members from one family affected with autosomal dominant pulmonary fibrosis (PF) and segregated with PF in this family (referred to as p.Arg957Trp, Borie R et al 2019. PubMed ID: 30523160). This variant is reported in 0.015% of alleles in individuals of East Asian descent in gnomAD. Together we classify the c.2941C>T variant as likely pathogenic.
Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 957 of the RTEL1 protein (p.Arg957Trp). This variant is present in population databases (rs398123018, gnomAD 0.01%). This missense change has been observed in individuals with dyskeratosis congenita (PMID: 23453664). This variant is also known as c.2941C>T (p.Arg981Trp). ClinVar contains an entry for this variant (Variation ID: 42021). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at